Precision BioSciences Future Growth
Future criteria checks 0/6
Precision BioSciences's revenue and earnings are forecast to decline at 1.2% and 11.7% per annum respectively while EPS is expected to grow by 26.7% per annum.
Key information
-11.7%
Earnings growth rate
26.7%
EPS growth rate
| Biotechs earnings growth | 21.2% |
| Revenue growth rate | -1.2% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 17 Apr 2024 |
Recent future growth updates
Recent updates
Analysts Just Made A Meaningful Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts
Aug 06
It's Down 29% But Precision BioSciences, Inc. (NASDAQ:DTIL) Could Be Riskier Than It Looks
Jun 23Is Precision BioSciences (NASDAQ:DTIL) Using Debt In A Risky Way?
Mar 14Is Precision BioSciences (NASDAQ:DTIL) Weighed On By Its Debt Load?
Dec 08Precision BioSciences appoints chief business officer from within ranks, rejigs co-founders' roles
Sep 02Precision BioSciences: CAR T Data Updates End Of 2022 And Plenty Of Cash
Aug 16Precision BioSciences Q2 2022 Earnings Preview
Aug 05Precision Bio: Another CAR-T Laggard With No Solid Prospects
May 09Despite Lacking Profits Precision BioSciences (NASDAQ:DTIL) Seems To Be On Top Of Its Debt
Apr 19Analyst Forecasts Just Became More Bearish On Precision BioSciences, Inc. (NASDAQ:DTIL)
Mar 21Precision BioSciences (NASDAQ:DTIL) Is Using Debt Safely
Dec 31Precision BioSciences: Uniquely Positioned
Oct 07Is Precision BioSciences (NASDAQ:DTIL) A Risky Investment?
Sep 24Precision BioSciences: The Right Profile To Progress
Aug 27Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 25 | -68 | -63 | 4 | 4 |
| 12/31/2025 | 21 | -60 | -59 | -31 | 5 |
| 12/31/2024 | 21 | -50 | -88 | -71 | 6 |
| 12/31/2023 | 49 | -43 | -86 | -84 | N/A |
| 9/30/2023 | 52 | -87 | -100 | -98 | N/A |
| 6/30/2023 | 47 | -89 | -49 | -45 | N/A |
| 3/31/2023 | 31 | -109 | -52 | -48 | N/A |
| 12/31/2022 | 25 | -73 | -49 | -46 | N/A |
| 9/30/2022 | 21 | -76 | -52 | -48 | N/A |
| 6/30/2022 | 38 | -93 | -105 | -101 | N/A |
| 3/31/2022 | 102 | -40 | -113 | -108 | N/A |
| 12/31/2021 | 116 | -31 | -17 | -11 | N/A |
| 9/30/2021 | 118 | -32 | -6 | -1 | N/A |
| 6/30/2021 | 101 | -47 | -4 | 1 | N/A |
| 3/31/2021 | 34 | -101 | 2 | 7 | N/A |
| 12/31/2020 | 24 | -109 | -92 | -87 | N/A |
| 9/30/2020 | 22 | -106 | -104 | -94 | N/A |
| 6/30/2020 | 19 | -101 | -101 | -86 | N/A |
| 3/31/2020 | 24 | -88 | -98 | -77 | N/A |
| 12/31/2019 | 22 | -93 | -96 | -71 | N/A |
| 9/30/2019 | 21 | -87 | -92 | -63 | N/A |
| 6/30/2019 | 18 | -76 | -92 | -64 | N/A |
| 3/31/2019 | 15 | -69 | -77 | -57 | N/A |
| 12/31/2018 | 11 | -46 | -67 | -52 | N/A |
| 9/30/2018 | 7 | -38 | -53 | -46 | N/A |
| 12/31/2017 | 6 | -21 | -30 | -24 | N/A |
| 12/31/2016 | 7 | -8 | N/A | 92 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DTIL is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: DTIL is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: DTIL is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: DTIL's revenue is expected to decline over the next 3 years (-1.2% per year).
High Growth Revenue: DTIL's revenue is forecast to decline over the next 3 years (-1.2% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DTIL's Return on Equity is forecast to be high in 3 years time